Enveric Receives U.S. Patent for Sleep, CNS Therapeutics
The patent strengthens Enveric Biosciences, Inc.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$2.14 | 1,000 | $2,140.00 | 1,000 | 2023-09-15 | Filing | |
$4.12 | 12,121 | $49,877.92 | 2,191,346 | 2017-11-17 | Filing | |
$4.12 | 100,000 | $411,500.00 | 2,972,592 | 2017-11-17 | Filing | |
$4.12 | 145,450 | $598,526.75 | 648,779 | 2017-11-17 | Filing | |
$6.50 | 1,303 | $8,468.72 | 13,910 | 2017-10-30 | Filing |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$0.29 | 58,850 | $17,243.05 | 2,250,000 | 2018-11-16 | Filing | |
$0.29 | 1,850 | $543.90 | 2,308,850 | 2018-11-16 | Filing | |
$0.30 | 6,657 | $1,963.82 | 2,310,700 | 2018-11-16 | Filing | |
$0.30 | 200 | $59.02 | 2,317,357 | 2018-11-16 | Filing | |
$0.30 | 15,251 | $4,575.30 | 2,317,557 | 2018-11-16 | Filing |